Skyscape Web Viewer : Physicians' Cancer Chemotherapy Drug Manual : Main Index

View All
lapatinib Breast Cancer Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs Lapatinib Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
larotrectinib Larotrectinib Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs Colorectal Cancer NTRK Gene Fusion Cancer Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
L-Asparaginase Leukemia Asparaginase ewinia chrysantemi-rywn Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
LBH 589
LEE-011
lenalidomide Leukemia Multiple Myeloma Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Lenalidomide Lymphoma Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs
lenvatinib Hepatocellular Cancer Renal Cell Cancer Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Lenvatinib Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Thyroid Cancer
Lenvima
letrozole Letrozole Breast Cancer
leucovorin Colorectal Cancer Gastric Cancer Leukemia Osteogenic Sarcoma Anal Cancer Esophageal Cancer Hepatocellular Cancer Lymphoma Pancreatic Cancer
leukemia
leuprolide Leuprolide Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs Prostate Cancer Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
Libtayo
lisocabtagene maraleucel Lisocabtagene maraleucel Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Lymphoma
L-leucovorin Colorectal Cancer Osteogenic Sarcoma
lanreotide
LDE225
Leukeran
Leustatin
liposomal irinotecan
liso-cel
lomustine Lomustine Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Brain Cancer Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs
loncastuximab
loncastuximab tesirine Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function
Lonsurf
lorazepam Common Regimens for Delayed and/or Breakthrough Nausea and Vomiting: Common Regimens for Chemotherapy-Induced Nausea and Vomiting
lorlatinib Lorlatinib Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs
LOXO-305
Lumakras
lung cancer